AOD9604 (10 x vials)

CA$120.00

AOD9604 is a peptide fragment derived from the human growth hormone (HGH) designed to target and reduce body fat. Here are its primary uses and benefits:

Uses and Benefits of AOD9604

  1. Fat Loss and Weight Management:

    • Lipolysis and Lipogenesis: AOD9604 promotes fat breakdown (lipolysis) and inhibits the formation of new fat (lipogenesis), making it effective for weight loss and fat reduction. This mechanism helps users burn more fat and calories, especially when combined with a healthy diet and exercise​ (Muscle and Brawn)​​ (Evolve)​.
    • Targeted Fat Reduction: The peptide is noted for its ability to preferentially target areas of the body where fat accumulation is common, such as the waistline and hips, enhancing localized fat reduction​ (MediSearch)​.
  2. Metabolic Health:

    • Improved Metabolism: AOD9604 helps regulate fat metabolism without impacting blood sugar levels, making it a safer alternative compared to other HGH-related treatments that may affect glucose levels​ (Evolve)​​ (Wikipedia)​.
    • No Impact on IGF-1: Unlike other HGH treatments, AOD9604 does not stimulate the production of insulin-like growth factor-1 (IGF-1), reducing the risk of adverse effects such as insulin resistance and hyperglycemia​ (Wikipedia)​.
  3. Bone and Cartilage Repair:

    • Potential Therapeutic Uses: Beyond fat loss, AOD9604 may aid in bone and cartilage repair, although these benefits are still under investigation and not as well-documented as its fat loss properties​ (Evolve)​.

Dosage and Administration

  • Typical Dosage: The standard dosage for AOD9604 is around 300 mcg per day, administered subcutaneously, preferably in the morning on an empty stomach. Dosages can vary, and it's recommended to follow specific guidelines or consult a healthcare provider​ (Muscle and Brawn)​​ (Evolve)​.
  • Cycle Length: Users are advised to use AOD9604 continuously for about 20 days, followed by a break to evaluate the body's response and minimize potential side effects​ (Muscle and Brawn)​.